Hungary’s Richter expands US footprint with strategic investment in biopharma company
3 Articles
3 Articles
Hungary’s Richter expands US footprint with strategic investment in biopharma company
CEE’s leading pharma Richter Gedeon has acquired a "significant stake" and entered into a business development partnership with Granata Bio, a US-based company specialising in reproductive health.
Granata Bio Receives Investment From Gedeon Richter
Granata Bio, a Boston, MA-based biotechnology company focused on advancing fertility therapeutics, received an investment from Gedeon Richter. The amount of the deal was not disclosed. The company intends to use the funds to expand operations and its R&D efforts. Led by CEO Evan Sussman, Granata Bio is a biopharmaceutical company which specializes in women’s […] The post Granata Bio Receives Investment From Gedeon Richter appeared first on FinSM…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage